Skip to main content
. 2017 May 10;7:1672. doi: 10.1038/s41598-017-01938-3

Figure 4.

Figure 4

Utilization of stem cell markers to identify MSCs in vivo at day 5 and day 10. (A,B) Immunofluorescent staining of MSCs markers in the scaffolds after subcutaneous implantation at day 5 (A) and day 10 (B). The scale bar indicates 100 μm. (C,D) Quantitative data for cell number of CD29-, CD44-, CD90-, and CD105-positive cells on scaffolds after subcutaneous implantation at day 5 (C) and day 10 (D). *p < 0.05 and **p < 0.01, respectively.